In this context, the data currently available on tirzepatide, showing its efficacy in glycemic control to the extent that a considerable percentage of patients achieve glucose levels indicative of diabetes remission [3, 59], as well as its high effectiveness in weight management, are promising regarding its future use in clinical practice
In particular, we found reduced efficacy for sustained insulin secretion with lixisenatide using an in vitro beta cell system, as well as reduced anti-hyperglycaemic and anorectic effects in mice
Some clinicians prefer this approach for its convenience and the potential for more concentrated telomerase activation
DeAngelis, R
Effectiveness of saxagliptin was not demonstrated in a 26-week, placebo-controlled, double-blind randomized clinical trial with a 26-week safety extension (NCT03199053) in 164 pediatric patients aged 10 to 17 years with inadequately controlled type 2 diabetes mellitus
This is normal as your skin adjusts to the treatment